DNA Study for Wegener’s Patients

The goal of Dr. Katherine Siminovitch’s study ‘Identification of Novel Wegener’s Granulomatosis Susceptibility Genes’ is to identify the genes that confer risk for Wegener’s. Results of this study have already confirmed the association of WG patients are required to provide the sensitivity required to identify such genes.

It is easy to participate in this study. Patients who enrol in the study will be asked to complete a few forms relating to their clinical symptoms and will be sent materials allowing for blood samples to be drawn at their doctor’s office or laboratory and shipped to Dr. Siminovitch.

Identification of WG susceptibility genes provides a promising avenue towards development of improved diagnostic and prognostic tests, as well as new targets for their therapeutic management.

All WG patients are eligible for the study, regardless of geographic location, age or gender.

To learn more about this study please contact Research Coordinator: Jennifer Campbell, Phone 1-416-946-4501 x 3297 Mount Sinai Hospital, Toronto, ON, Canada or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it